Open AccessMicropapillary or solid pattern predicts recurrence free survival benefit from adjuvant chemotherapy in patients with stage IB lung adenocarcinoma
Author(s) -
Minjie Ma,
Yunlang She,
Yijiu Ren,
Chenyang Dai,
Lei Zhang,
Huikang Xie,
Chunyan Wu,
Minglei Yang,
Dong Xie,
Chang Chen
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.08.64
Subject(s) - medicine , hazard ratio , adenocarcinoma , confidence interval , stage (stratigraphy) , univariate analysis , carcinoembryonic antigen , adjuvant chemotherapy , gastroenterology , multivariate analysis , oncology , chemotherapy , proportional hazards model , adjuvant , lung , subgroup analysis , cancer , paleontology , breast cancer , biology
Our study aimed to evaluate the prognostic significance and adjuvant chemotherapy (ACT) benefits of a micropapillary/solid (MS) pattern in patients with stage IB lung adenocarcinoma.